Trial NCT01067326

View at ClinicalTrials.gov 
Org. Study IDs: 09-007617
Secondary IDs: R01AG031750 R01HL092954

Last trial update was posted on 2013-02-13

MeSH Interventions

Aliskiren

MeSH Conditions

Atherosclerosis

Other Conditions

Endothelial Dysfunction

Stopping Reasons

Novartis ended all studies regarding Aliskiren.

Limitations And Caveats

The study was terminated early due to safety concerns from the ALTITUDE trial; there was an unexpected increase in adverse events (non-fatal stroke, renal complications, hyperkalemia and hypotension). Novartis ended all studies regarding Aliskiren.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID